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1. Abstract 
 
 Microdialysis sampling uses a semi-permeable membrane to allow solute collection by 
diffusion. When used in conjunction with other instruments, analytes in question can be 
quantified. Matrix Metalloproteinases (MMPs) are enzymes involved in numerous biological 
processes where they serve the role of degrading extracellular matrix. Microdialysis sampling, 
in coordination with further analysis methods, can be used in order to measure the activity of 
these enzymes in a region of the body instantaneously. The intention of this project is to 
determine ways of measuring in vitro activity of elastase from porcine pancreas using 
determined activity values and the collection of elastase products. This is a necessary step in 
the advancement of this technology towards in vivo research. Elastase from the porcine 
pancreas is a substitute for MMP in vivo. Experiments were performed using succinyl(Ala)3-p-
nitroaniline, 4-nitroanaline, and elastase from porcine pancreas. The Nanodrop, a UV-Vis 
instrument, was used in order to measure the concentration of p-nitroaniline (p-NA) using its 
maximum absorbance at a wavelength of 380 nm. A microdialysis probe with a molecular cutoff 
of 20 kDa was used in order to collect p-NA from solution and transfer it into collection vials for 
analyzation of p-NA concentration. The concentration of p-NA increased over time until it 
reached a point where it would level off. This level-off value varied based upon the 
concentration of the suc-(Ala)3-pNA perfusate. Experiments showed a decrease in activity of 
elastase with decreasing concentrations or increasing storage time. In microdialysis sampling 
experiments, the concentration of suc-(Ala)3-pNA in the samples collected showed a decrease 
as the concentration of the pNA collected increased.  
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2. Introduction 
 
2.1 Overview of Experiment 
 This research chiefly focuses on the enzyme elastase derived from the porcine pancreas 
in addition to succinyl(Ala)3-p-nitroaniline, the commonly used substrate, and 4-nitroaniline, 
the product of the reaction between the two chemicals previously mentioned. The long term 
goal of this research is to be able to measure the activity of an enzyme in vivo using known 
perfusate concentrations and concentration of specific chemicals in the collected solution. The 
measurement of in situ biochemistry would allow for real-time activities to be measured and 
analyzed, allowing further conclusions regarding the nature of biochemistry in vivo. It is 
necessary to conclude accurate results; there is a necessity for increased confidence when 
performing in vivo analysis. The onset of this project centered on the activity of the elastase 
enzyme at different concentrations in sodium phosphate buffer (pH= 7.1.) After several 
experiments using the TECAN instrument, focus shifted to the measurement of p-NA collected 
from the microdialysis probe inserted in a solution of elastase (at varying concentrations) with 
succinyl(Ala)3-p-nitroaniline being used as the substrate. The final objective of this project is to 
be able to accurately measure the activity of the elastase enzyme in solution using the 
calculated activity and the concentrations of p-NA collected through microdialysis methods.   
2.2 Microdialysis Sampling 
 
2.2.1 Microdialysis Sampling- Basic Setup and Usage 
 Microdialysis is a sampling technique that uses concentration-based passive diffusion of 
solutes across a semi-permeable hollow-fiber membrane to collect analytes from a solution. 
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Microdialysis probes consist of inlet and outlet tubes leading to/away from the cylindrical 
semipermeable membrane of the probe. The inlet tube carries the perfusate, to be released 
through the semipermeable membrane into solution, while the outlet tube carries the dialysate 
collected through the same semipermeable membrane in the same solution. The basic set-up of 
a microdialysis probe can be seen in Figure 1. The semipermeable membrane is unique to the 
type of probe purchased; different probes have membranes with different molecular weight 
cutoffs in order to specify the analytes to be collected. The molecular weight cutoff of the 
probes used in these experiments is 20 kDa.  
 
 
 
 
Figure 1. Schematic representation of a microdialysis probe with inlet and outlet flow 
represented.1 
 
 
Microdialysis sampling as a whole consists of four separate devices: a syringe, syringe 
pump, microdialysis probe, and collection vial are all used during the course of sampling. The 
syringe contains the perfusate to be pumped into the inlet tube of the microdialysis probe, as 
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detailed above. The syringe pump flows the perfusate into the probe at slow rates; flow rates 
are maintained at less than 4μL/min in order to prevent damage to the microdialysis probe 
membrane. The collection vial is placed at the end of the outlet tube to collect the dialysate, a 
sample of fluid that comes from the solution and is representative of the composition of said 
solution. The typical setup is shown below in Figure 2. 
 
 
Figure 2. Image detailing typical set up of in vitro microdialysis sampling experiment. Syringe 
pump loaded with syringes can be seen on the left, connected to the microdialysis probe in 
solution, with the outlet running to a vial on the right. 
 
  
Microdialysis methods can be used in conjunction with other analytical measurement 
techniques to monitor the real-time levels of analyte concentration in vivo. This is useful during 
in vivo studies, as previously it was necessary for animals to be sacrificed at each time interval 
so that measurements could be made. With microdialysis sampling, the animal being studied 
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can be kept alive through the duration of the sampling and real-time results from microdialysis 
sampling can be obtained simultaneously.  
 Microdialysis research began as a tool for measuring neurotransmitters in the brain but 
the application of this sampling method has since broadened. In part because of its minimally 
invasive nature, it has grown as an in vivo sampling option for molecules within the 
extracellular space of many tissues and body fluids, including blood and cerebrospinal fluid 
(CSF.) It is now used for studies in nearly every organ.2  
 
2.2.2 Quantification of Concentrations in Microdialysis Dialysate  
 Once the dialysate from the microdialysis probe is collected in vials, specific methods 
are needed in order to quantify the amount of the targeted analyte. The fraction of product 
obtained is related to the concentration of the enzyme in solution. Analyte concentrations 
obtained from the dialysate can be related to the concentration in solution by using the 
membrane extraction efficiency.3 In Equation 1, EE represents the extraction efficiency, and the 
Coutlet represents the concentration of the analyte in the outlet (dialysate), Cinlet the 
concentration of the analyte in the inlet (perfusate), and Csample the concentration of the 
analyte in the sample solution far away from the probe.3  
𝐸𝐸 =
 𝐶𝑜𝑢𝑡𝑙𝑒𝑡−𝐶𝑖𝑛𝑙𝑒𝑡
𝐶𝑠𝑎𝑚𝑝𝑙𝑒−𝐶𝑖𝑛𝑙𝑒𝑡
      (1)4 
 There are many different variations of microdialysis sampling technique that affect the 
recovery rate. The molecular weight cutoff of the probe must be such that the analyte in 
question will have the ability to leave the probe and also reenter, while other substances may 
not cross this probe membrane. Microdialysis probes with 20 kiloDalton (kDa) and 100 kDa 
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probes were used in lab, but for these experiments 20 kDa was used. This cutoff will not allow 
any molecule over a certain size to pass through the pores. The relative recovery of a molecule 
with size above the molecular weight cutoff will be very small, while a molecule under this 
cutoff may remain high, with other factors to define the relative recovery. The diffusion 
coefficient of the analyte must also be taken into account with regards to microdialysis 
sampling. Varying diffusion coefficients will affect the recovery of analyte and the 
corresponding dialysate. 
 The flow rate of the perfusate will also lead to variations in the relative recovery.4 With 
slower flow rates, the perfusate will have more time to interact with enzymes in the solution, 
and thus the concentration of the analyte at the outlet will be increased. With faster flow rates, 
there is not as much time for a reaction to occur, so the analyte in question will have lower 
concentrations. This is modeled below in Figure 3, which shows a mathematical simulation of 
relative recovery (RR) is based upon the flow rate of the perfusate.   
 
Figure 3. Simulated relative recovery (RR) curves as a function of perfusion flow rates in 
microliters/minute. This uses Bungay’s model for glucose (black), insulin (red), and MCP-1 
(green).8 
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 These factors must be taken into account when comparing relative recovery between 
experiments with different parameters. The relative recovery depends upon more than just 
concentration of enzymes and the perfusate, it also depends upon the flow rate and molecular 
weight cutoff of the experimental setup.  
  
2.3 Matrix Metalloproteinases  
 
 Matrix metalloproteinases (MMPs), also referred to as matrixins, have been associated 
with the degradation and turnover of most of the components of the extracellular matrix 
(ECM).6 MMPs all share a conserved zinc-binding motif in their catalytic site.10 These enzymes 
have recently been researched for their function as regulators of extracellular tissue signaling 
networks in addition to the degradation of ECM.10 These metalloproteinases play a role in 
numerous biological processes. MMPs play an important role in embryogenesis, normal tissue 
remodeling, wound healing, and angiogenesis, to name a few processes.8 MMPs are 
upregulated in diseases such as atheroma, arthritis, cancer and tissue ulceration.11 There are 
currently 23 different MMPs identified in humans, each with varying functions.11 MMPs are 
difficult to quantify using traditional immunochemical methods because the total enzyme 
concentration does not accurately portray the concentration of active enzyme. MMPs are 
released as pro-enzymes into the ECM and then are converted here into their active form.12 
These two forms cannot be distinguished between by immunochemical methods, so 
microdialysis methods are being developed to measure the MMP activity values in real-time.12  
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MMP-12 is one of these enzymes which degrade elastin in the extracellular matrix.12 
MMP-12 is also known as macrophage metalloelastase and is the predominant cell type which 
patrols the lower airspaces of the lungs under normal conditions.12 This enzyme is important in 
current research because of the similarity to porcine pancreatic elastase. Porcine pancreatic 
elastase is used in experiments as a substitute for MMP-12 because the cost is far lower and 
the function is very similar to that of MMP-12, in that each cleaves the same substrate. Porcine 
pancreatic elastase cleaves succinyl-L-trialanine p-nitroanilide in order to form p-Nitroaniline 
(p-NA) and another product, as shown in Figure 4 below.  
 
 
Figure 4. Schematic for indirect detection of elastase. Example of MMP-12-like elastase 
cleavage of Suc(Ala)3-p-NA as used in experiments. Note: HPLC was not used in the following 
experiments as listed on the figure.13 
 
This p-NA product is useful in research because the concentration can be measured 
using the absorbance values of a corresponding solution. Collected p-NA was analyzed on the 
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NanoDrop instrument to measure the absorbance value of the solution. This was able to be 
converted into concentration values.  
3. Materials and Methods 
3.1 Chemicals 
 
 Succinyl(Ala)3-p-nitroaniline, 4-nitroanaline, and porcine pancreatic elastase were all 
used in the experiments conducted in lab. All chemicals were acquired from Sigma in St. Louis, 
Missouri. When conducting experiments, 1000 µM elastase and succinyl(Ala)3-p-nitroaniline 
solutions in sodium phosphate buffer (pH=7.1) were prepared fresh at the beginning of each 
day. Degradation of these materials was found when stored. The maximum absorbance of both 
succinyl(Ala)3-p-nitroaniline and 4-nitroanaline were found in previous experiments to be 315 
nm and 380 nm, respectively.14 The molecular weight of suc(Ala)3-p-NA is 451.43 Daltons5, the 
molecular weight for p-Nitroaniline is 138.12 Daltons6, and the molecular weight of the elastase 
enzyme is 25.9 kDa7; the membrane used keeps the enzyme from passing. 
 
3.2 Instruments 
 
CMA 20 Elite 10mm microdialysis probes from CMA Microdialysis with a molecular 
weight cutoff of 20 kDa were used during experiments. Both the pump and the 1 mL syringe 
used were from BASi. A NanoDrop 2000c spectrophotometer from Thermo Scientific was used 
in conjunction with NanoDrop 2000 software in order to measure the absorbance of solutions 
collected. 2 µL samples were analyzed by the NanoDrop instrument. A TECAN instrument, 
model infinite M200, was used with corresponding TECAN i-control software in order to 
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measure the activity of the porcine panctreatic elastase over time. 100 µL samples were 
analyzed by the TECAN instrument to measure absorbance over time as the reaction of elastase 
and succinyl(Ala)3-p-nitroaniline proceeded.  
 
 
3.3 Porcine Pancreatic Elastase Activity 
 
 The activity of elastase was measured using the TECAN instrument, which is 
capable of measuring absorbance over time as the reaction of elastase and succinyl(Ala)3-p-
nitroaniline proceeded. A 96 well plate was used, and 50 microliters of 500 micromolar 
succinyl(Ala)3-p-nitroaniline was combined with 50 microliters of porcine pancreatic elastase at 
different concentrations to test for the activity of the enzyme. Elastase concentrations of 1, 0.5, 
and 0.25 units per milliliter were used in these experiments. 
The following screenshot (Figure 5) was obtained from TECAN i-control software which 
was used during each run of porcine pancreatic elastase and succinyl(Ala)3-p-nitroaniline. A 
kinetic cycle was run with readings in each highlighted well every 15 seconds. Absorbance 
values of 380 nm and 315 nm were each obtained to track the activity of the elastase enzyme. 
Movement of the plate was also added into the code, as proper mixing was difficult at such 
small volumes.   
                                                                                                                                                          Young   14 
 
Figure 5. TECAN i-control software code for each run of porcine pancreatic elastase and 
succinyl(Ala)3-p-nitroaniline. Absorbance values were calculated at every 15 second interval for 
each well.  
 
3.3.1 Porcine Pancreatic Elastase Degradation 
 
During measurement of porcine pancreatic elastase activity, it was noticed that the 
activity was greatly decreased upon storage. Experiments were run using the TECAN and slopes 
were compared between freshly-made enzyme solution and solution stored for one day. The 
same TECAN i-control software was used as above, and the slopes were compared using 
Microsoft Excel.    
 
3.4 Measuring Collected p-NA and suc-(Ala)3-pNA Concentrations 
 
Once the dialysate from the microdialysis probe is collected in vials, the absorbance 
must be measured in order to determine the concentration of both pNA and suc-(Ala)3-pNA 
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collected. In order to determine the concentration of each substance, calibration curves are 
developed before the experiment begins and used to compare the absorption values measured 
from the collection vial.  
Calibration curves are created at both 315 nm, the peak absorbance of suc-(Ala)3-pNA, 
and 380 nm, the peak absorbance of pNA, for both substances, resulting in 4 calibration curves. 
Using the measured absorbance of our dialysate, matrix algebra can be used in order to 
determine the concentration of both pNA and suc-(Ala)3-pNA. The following Equations 3-6 
represent the mathematics that was followed in order to determine each concentration value, 
where 𝐴 represents the total absorbance of the dialysate, ∈ represents the slope of the 
calibration curve for the corresponding grah, 𝐶𝑥 represents the concentration of x, ℓ is the 
pathlength of the light (this is a constant and can thus be ignored in succeeding equations), and 
𝜆1 and 𝜆2 represent the wavelength of light used. For this experiment, 𝜆1 was 315 nm and 𝜆2 
was 380 nm.  
𝐴𝑇𝑜𝑡𝑎𝑙(𝜆1) =∈𝑝𝑁𝐴(𝜆1) ℓ 𝐶𝑝𝑁𝐴 +  ∈suc−(Ala)3−pNA(𝜆1) ℓ 𝐶suc−(Ala)3−pNA                (3)             
𝐴𝑇𝑜𝑡𝑎𝑙(𝜆2) =∈𝑝𝑁𝐴(𝜆2) ℓ 𝐶𝑝𝑁𝐴 +  ∈suc−(Ala)3−pNA(𝜆2) ℓ 𝐶suc−(Ala)3−pNA                 (4) 
 
(
𝐴𝑇𝑜𝑡𝑎𝑙(𝜆1)
𝐴𝑇𝑜𝑡𝑎𝑙(𝜆2)
) = (
∈𝑝𝑁𝐴(𝜆1)  ∈suc−(Ala)3−pNA(𝜆1)
∈𝑝𝑁𝐴(𝜆2)  ∈suc−(Ala)3−pNA(𝜆2)
) (
𝐶𝑝𝑁𝐴
𝐶suc−(Ala)3−pNA
)                     (5) 
(
∈𝑝𝑁𝐴(𝜆1)  ∈suc−(Ala)3−pNA(𝜆1)
∈𝑝𝑁𝐴(𝜆2)  ∈suc−(Ala)3−pNA(𝜆2)
)
−1
(
𝐴𝑇𝑜𝑡𝑎𝑙(𝜆1)
𝐴𝑇𝑜𝑡𝑎𝑙(𝜆2)
) = (
𝐶𝑝𝑁𝐴
𝐶suc−(Ala)3−pNA
)               (6)  
 
 Following the mathematical steps outline in Equations 3-6, the absorbance values 
obtained from the NanoDrop instrument for the dialysate were converted into concentration 
values using Microsoft Excel.  
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4. Results and Discussion 
 
4.1 Degradation of Stored Elastase Solutions   
 During the testing of porcine pancreatic elastase activity, it was noted that there was a 
vast difference between activity on the day the solution was created and on the following day. 
Porcine pancreatic elastase was diluted in sodium phosphate buffer with a pH of 7.1, and 
stored frozen at -20 C for use later. However, when thawed and tested the next day a large 
drop-off was seen. In order to test for this drop-off, experiments were run to show the 
difference between the first day and the next day, as shown in Figure 6 and 7.  
 
 
 
Figure 6. Absorbance values as a function of time as measured on the TECAN instrument. 
Porcine pancreatic elastase in sodium phosphate buffer (20 C, ph=7.1.) Slope in B2 at 1 unit/mL 
is 3.17 x 10-4 s-1 and slope in B3 at 1 unit/mL is 3.20 x 10-4 s-1.  
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Figure 7. Absorbance values as a function of time as measured on the TECAN instrument. 
Porcine pancreatic elastase in sodium phosphate buffer (20 C, ph=7.1.) Slope in A2 at 1 unit/mL 
is 1.09 x 10-4 s-1 and slope in A3 at 1 unit/mL is 1.21 x 10-4 s-1.  
 
 
In Figure 6, the slopes are .000317 and .000320 for 1 unit/mL fresh elastase enzyme, 
and in Figure 7 the slopes are .000109 and .000121 for day-old enzyme solution. Clearly, a large 
decrease was seen in the slopes for the elastase enzyme from one day to the next. It was 
decided that it would be necessary to make a fresh solution of pancreatic porcine elastase and 
sodium phosphate buffer (pH = 7.1) in order to prevent this decreased activity. This degradation 
of the elastase enzyme would have created issues in microdialysis sampling experiments should 
stored samples have been used when running experiments.  
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4.2 Elastase Activity  
 Porcine pancreatic elastase activity was measured by first determining the slope of the 
absorbance as a function of time and comparing between different parameters. This project 
started with comparing activity between solutions with different concentrations of the elastase 
enzyme. Samples with 0.25 unit/mL, 0.5 unit/mL and 1 unit/mL elastase were compared to see 
differences in slopes. It was determined that the slope was decreased when the concentration 
of the enzyme in solution was decreased. The data points generated by the TECAN instrument 
were transferred to Microsoft Excel in order to generate Figures 8, 9, and 10 below. 
 
 
Figure 8. Absorbance values as a function of time as measured on the TECAN instrument. 
Porcine pancreatic elastase in sodium phosphate buffer (20 C, ph=7.1.) Slope in B2 at 1 unit/mL 
is 3.17 x 10-4 s-1 and slope in B3 at 1 unit/mL is 3.20 x 10-4 s-1.  
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Figure 9. Absorbance values as a function of time as measured on the TECAN instrument. 
Porcine pancreatic elastase in sodium phosphate buffer (20 C, ph=7.1.) Slope in E2 at 0.5 
unit/mL is 1.65 x 10-4 s-1 and slope in E3 at 0.5 unit/mL is 1.63 x 10-4 s-1.  
 
 
 
 
Figure 10. Absorbance values as a function of time as measured on the TECAN instrument. 
Porcine pancreatic elastase in sodium phosphate buffer (20 C, ph=7.1.) Slope in A2 at 0.25 
unit/mL is 7.55 x 10-5 s-1 and slope in A3 at 0.25 unit/mL is 7.48 x 10-5 s-1.  
 
 To organize the graphs above, Table 1 was created. It gives the values of the slope for 
each well, where each concentration of elastase was run in duplicate.  
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Table 1. Slope of absorbance values as a function of time for different concentrations of porcine 
pancreatic elastase in sodium phosphate buffer (pH=7.1). Average slope at each elastase 
concentration has also been calculated in Column 4.  
Elastase Conc. Slope Values (s-1) Average Slope (s-1) 
1 unit/mL 3.17 x 10-4 3.20 x 10-4 3.185 x 10-4 
0.5 unit/mL 1.65 x 10-4 1.63 x 10-4 1.64 x 10-4 
0.25 unit/mL 7.55 x 10-5 7.48 x 10-5 7.515 x 10-5 
 
It can be seen in Table 1 that there is a decrease in the average slope as the elastase 
concentration decreases. This seems to coincide with the idea that there will be less activity 
when there is less enzyme available. Because of the lower activity, there is a smaller change in 
the absorbance over time and thus a less steep graph. By calculating the activity at each 
concentration, these values can be used in order to create a mathematical modelling system to 
determine the concentration of elastase during an in vivo sampling procedure. 
4.3 Measuring Collected p-NA and suc-(Ala)3-pNA 
 
 In order to measure the concentration of the collected pNA and suc-(Ala)3-pNA, 
calibration curves must first be developed for each chemical. These calibration curves will be 
used in the matrix algebra necessary for calculation of concentrations. Upon the determination 
of calibration curves on the NanoDrop instrument, the absorbance values of our collected 
dialysate can be used in order to determine the concentration of analytes collected.   
4.3.1 Generation of Calibration Curves  
 
 To create the p-NA calibration curve, a solution of 1000 micromolar p-NA was created 
using roughly 1.38 mg p-NA in 10 mL of sodium phosphate buffer, and then mixed on a mixing 
plate with a magnetic stir bar and very low heat. After about 30 minutes, when there was no 
more p-NA visible, the solution was removed from the mixing plate. At this point, 1 mL was 
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placed into a vial labelled 1000 µM. 7 other vials were then used in order to create a serial 
dilution of p-NA with concentrations of 500 µM, 250 µM, 125 µM, 62.5 µM, 31.25 µM, 15.625 
µM, 7.8125 µM, and 3.90625 µM. Each vial was mixed thoroughly to ensure uniform 
concentrations of p-NA. A 2 µL sample of each was then run on the NanoDrop instrument in 
order to determine the absorbance value at each concentration. Absorbance values were 
calculated at both 315 nm and 380 nm. Each vial was run in triplicate. Figures 11 and 12 
(below) were generated using absorbance values.  
 
Figure 11. Calibration curve for p-NA solutions between 3.90625 micromolar and 1000 
micromolar concentrations at a wavelength of 315 nm. (Slope= 4.129 x 10-4) 
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Figure 12. Calibration curve for p-NA solutions between 3.8 micromolar and 1000 micromolar 
concentrations at a wavelength of 380 nm. (Slope= 1.495 x 10-3) 
 
 
 To create the suc-(Ala)3-pNA calibration curve, a solution of 1000 micromolar suc-(Ala)3-
pNA was created using roughly .9029 mg suc-(Ala)3-pNA in 2 mL of sodium phosphate buffer 
(pH=7.1), and then mixed on a mixing plate with a magnetic stir bar. Because suc-(Ala)3-pNA is 
much more soluble that p-NA, it does not need heat or as much time to fully dissolve. After a 
few minutes of mixing, the solution was removed from the mixing plate. At this point, 1 mL was 
placed into a vial labelled 1000 µM. 7 other vials were then used in order to create a serial 
dilution of p-NA with concentrations of 500 µM, 250 µM, 125 µM, 62.5 µM, 31.25 µM, 15.625 
µM, 7.8125 µM, and 3.90625 µM. Each vial was mixed thoroughly to ensure uniform 
concentrations of suc-(Ala)3-pNA. A 2 µL sample of each was then run on the NanoDrop 
instrument in order to determine the absorbance value at each concentration. Absorbance 
values were calculated at both 315 nm and 380 nm.  Each vial was run in triplicate. Figures 13 
and 14 (below) were generated from the absorbance values obtained.  
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Figure 13. Calibration curve for suc-(Ala)3-pNA solutions between 3.60925 micromolar and 1000 
micromolar concentrations at a wavelength of 315 nm. (Slope= 1.348 x 10-3) 
 
 
Figure 14. Calibration curve for suc-(Ala)3-pNA solutions between 3.60925 micromolar and 1000 
micromolar concentrations at a wavelength of 380 nm. (Slope= 1.164 x 10-4) 
  
 
Slopes were then collected from each graph in order to plug into Equations 3-6 as 
described above. To simplify the charts above, a 2x2 matrix of the slopes was created with 
orientation identical to that of Equation 5. Table 2 shows the slopes of each graph that was 
generated for the calibration curves of p-NA and suc-(Ala)3-pNA at 315 nm and 380 nm.  
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Table 2. Slope values for each generated calibration curve for p-NA and suc-(Ala)3-pNA at 315 
nm and 380 nm. Solutions contained p-NA or suc-(Ala)3-pNA at different concentrations in 
sodium phosphate buffer (pH=7.1).   
 
Wavelength (nm) 
315 380 
p-NA 4.129 x 10-4 1.495 x 10-3 
suc-(Ala)3-pNA  1.348 x 10-3 1.164 x 10-4 
 
 These values for the slope of each calibration curve were inserted into Equation 5 as 
listed above. The matrix in Equation 7 was obtained.  
(
∈𝒑𝑵𝑨(𝝀𝟏)  ∈suc−(Ala)3−pNA(𝝀𝟏)
∈𝒑𝑵𝑨(𝝀𝟐)  ∈suc−(Ala)3−pNA(𝝀𝟐)
) = (
∈𝒑𝑵𝑨(𝟑𝟏𝟓𝒏𝒎)  ∈suc−(Ala)3−pNA(𝟑𝟏𝟓𝒏𝒎)
∈𝒑𝑵𝑨(𝟑𝟖𝟎𝒏𝒎)  ∈suc−(Ala)3−pNA(𝟑𝟖𝟎𝒏𝒎)
) = (
. 0004129  .001348
. 001495 . 0001164
)         (7) 
 
 
4.3.2 Translation from Absorbance Values to Concentration Values   
 To translate the absorbance values collected at each time point to values of 
concentration for p-NA and suc-(Ala)3-pNA, Equations 3-7 were used. Absorbance values of 
wells were gathered in triplicate, and the concentrations associated were found using 
Equations 8 and 9 below, where 𝐴𝑇𝑜𝑡𝑎𝑙(315𝑛𝑚) represents the absorbance value of the vial at 
315 nm, and 𝐴𝑇𝑜𝑡𝑎𝑙(380) represents the absorbance value of the value measured with 
wavelength of 380 nm.  
(
∈𝑝𝑁𝐴(315𝑛𝑚)  ∈suc−(Ala)3−pNA(315𝑛𝑚)
∈𝑝𝑁𝐴(380𝑛𝑚)  ∈suc−(Ala)3−pNA(380𝑛𝑚)
)
−1
(
𝐴𝑇𝑜𝑡𝑎𝑙(315𝑛𝑚)
𝐴𝑇𝑜𝑡𝑎𝑙(380𝑛𝑚)
) = (
𝐶𝑝𝑁𝐴
𝐶suc−(Ala)3−pNA
)               (8)  
(
. 0004129  .001348
. 001495 . 0001164
)
−1
(
𝐴𝑇𝑜𝑡𝑎𝑙(315𝑛𝑚)
𝐴𝑇𝑜𝑡𝑎𝑙(380𝑛𝑚)
) = (
𝐶𝑝𝑁𝐴
𝐶suc−(Ala)3−pNA
)                               (9) 
 
 
Matrix algebra was used in order to determine the concentrations of p-NA and suc-
(Ala)3-pNA and graphs were created from these calculated data points, as shown below in 
Figures 15-20.   
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Figure 15. Concentration of p-NA as a function of time. Samples were collected and measured 
every 5 minutes for 65 minutes. 500 micromolar suc-(Ala)3-pNA was flowed at 1 microliter per 
minute. Microdialysis probe was placed in 0.5 unit/mL solution of porcine pancreatic elastase, 
diluted in sodium phosphate buffer (pH=7.1.)  
 
 
Figure 16. Concentration of suc-(Ala)3-pNA as a function of time. Samples were collected and 
measured every 5 minutes for 65 minutes. 500 micromolar suc-(Ala)3-pNA was flowed at 1 
microliter per minute. Microdialysis probe was placed in 0.5 unit/mL solution of porcine 
pancreatic elastase, diluted in sodium phosphate buffer (pH=7.1.)  
 
 
 Figure 15 shows an increase in the concentration of p-NA, as expected. It does show a 
levelling-off of the p-NA concentration collected around 40 minutes in the 45-50 micromolar 
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range. The concentration of suc-(Ala)3-pNA shown in Figure 16 shows a steep drop-off from the 
5 minute sample to the 10 minute sample, but then a levelling-off after this point. The suc-
(Ala)3-pNA concentration levels off around 250 micromolar in each subsequent sample.   
 
 
Figure 17. Concentration of p-NA as a function of time. Samples were collected and measured 
every 5 minutes for 65 minutes. 500 micromolar suc-(Ala)3-pNA was flowed at 1 microliter per 
minute. Microdialysis probe was placed in 0.5 unit/mL solution of porcine pancreatic elastase, 
diluted in sodium phosphate buffer (pH=7.1.)  
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Figure 18. Concentration of suc-(Ala)3-pNA as a function of time. Samples were collected and 
measured every 5 minutes for 65 minutes. 500 micromolar suc-(Ala)3-pNA was flowed at 1 
microliter per minute. Microdialysis probe was placed in 0.5 unit/mL solution of porcine 
pancreatic elastase, diluted in sodium phosphate buffer (pH=7.1.)  
 
 
 Figure 17 shows an increase in the concentration of p-NA once again, as expected. It 
does show a levelling-off of the p-NA concentration collected around 20 minutes in the 60-70 
micromolar range. The data point at 30 minutes with a concentration of 93.875 micromolar p-
NA appears to be an outlier. This experiment was run with the same parameters as the one 
which generated the preceding Figures 15 and 16. However, the p-NA concentration measured 
leveled off at different times and at different values. This may be due to small errors in the 
concentration of any substrate used or differences in the flow rate of two different syringe 
pumps. This experiment would need to be run several more times in order to produce 
replicable values. It does appear from these two graphs that the general shape and behavior of 
the concentrations is consistent with one another, the values just vary. The concentration of 
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suc-(Ala)3-pNA shown in Figure 18 shows a gradual drop-off for most of the first 60 minutes, 
with a sudden rise at 65 minutes.   
 
 
Figure 19. Concentration of p-NA as a function of time. Samples were collected and measured 
every 5 minutes for 45 minutes. 1000 micromolar suc-(Ala)3-pNA was flowed at 1 microliter per 
minute. Microdialysis probe was placed in 0.5 unit/mL solution of porcine pancreatic elastase, 
diluted in sodium phosphate buffer (pH=7.1.)  
 
 
Figure 20. Concentration of suc-(Ala)3-pNA as a function of time. Samples were collected and 
measured every 5 minutes for 45 minutes. 1000 micromolar suc-(Ala)3-pNA was flowed at 1 
microliter per minute. Microdialysis probe was placed in 0.5 unit/mL solution of porcine 
pancreatic elastase, diluted in sodium phosphate buffer (pH=7.1.)  
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 Figure 19 shows an increase in the concentration of p-NA once again, in a similar fashion 
the preceeding experiments. It shows a levelling-off of the p-NA concentration collected around 
30 minutes in the 125-135 micromolar range. This experiment was run with slightly different 
parameters as the one which generated the preceding Figures 15-18. The flow rate was the 
same, as was the concentration of the enzyme. The concentration of the perfusing suc-(Ala)3-
pNA solution was doubled to 1000 micromolar. This did create a rough doubling of the leveling-
off concentration for p-NA.  The concentration of suc-(Ala)3-pNA measured, and portrayed in 
Figure 20, appears to have no correlation. This is not expected; it was expected that the 
concentration of suc-(Ala)3-pNA would decrease over time. To rise and fall with such drastic 
values does not seem to satisfy this expected outcome. This may be due to the high 
concentration of suc-(Ala)3-pNA and so slight changes may be amplified in the calculated 
concentrations. This experiment would need to be run several more times in order to produce 
replicable values for the concentration values over time in order to create a mathematical 
model for the measurement of in vivo concentration for such an enzyme.  
 
5. Conclusion 
 
Research into the activity of porcine pancreatic elastase revealed differences in the 
slope of absorbance as a function of time when elastase and suc-(Ala)3-pNA were combined in a 
well. Different enzyme concentrations altered the slope (steeper for higher concentrations) and 
time in storage also created differences in activity. It was determined that the activity of 
enzyme solutions stored for a day was much lower than fresh solutions. Further research is 
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currently being conducted to determine reproducible results regarding the activity of porcine 
pancreatic elastase at different concentrations and with different factors altered. During 
microdialysis research using suc-(Ala)3-pNA as the perfusate and elastase as the enzyme, the 
concentration of p-nitroaniline collected increased at each early time point, signifying that the 
microdialysis setup was working as expected. The values obtained for the suc-(Ala)3-pNA 
concentration were not as expected, however. In one the third experiment, shown in Figure 20, 
the concentrations do not appear to be correlated in any way. These experiments should be run 
several more times in order to produce replicatable results in order to use the information 
gained to develop a mathematical model of measuring in vivo enzyme concentration 
accurately.   
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